Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 3
2005 2
2006 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.
Mahasreshti PJ, Navarro JG, Kataram M, Wang MH, Carey D, Siegal GP, Barnes MN, Nettelbeck DM, Alvarez RD, Hemminki A, Curiel DT. Mahasreshti PJ, et al. Among authors: kataram m. Clin Cancer Res. 2001 Jul;7(7):2057-66. Clin Cancer Res. 2001. PMID: 11448924 Free article.
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
Kirby TO, Rivera A, Rein D, Wang M, Ulasov I, Breidenbach M, Kataram M, Contreras JL, Krumdieck C, Yamamoto M, Rots MG, Haisma HJ, Alvarez RD, Mahasreshti PJ, Curiel DT. Kirby TO, et al. Among authors: kataram m. Clin Cancer Res. 2004 Dec 15;10(24):8697-703. doi: 10.1158/1078-0432.CCR-04-1166. Clin Cancer Res. 2004. PMID: 15623655 Free article.
Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy.
Mahasreshti PJ, Kataram M, Wu H, Yalavarthy LP, Carey D, Fisher PB, Chada S, Alvarez RD, Haisma HJ, Dent P, Curiel DT. Mahasreshti PJ, et al. Among authors: kataram m. Gynecol Oncol. 2006 Mar;100(3):521-32. doi: 10.1016/j.ygyno.2005.08.042. Epub 2005 Oct 12. Gynecol Oncol. 2006. PMID: 16225913